SAN DIEGO – ResMed revenue for the quarter quarter ended March 31, 2016, was $453.9 million, a 7% increase compared with the quarter ended March 31, 2015. This is a 9% increase on a constant currency basis.
“We have seen sustained success with the execution of our healthcare informatics strategy driving seven consecutive quarters of device growth, since the Q1 2015 launch of our Air Solutions platform,” said Mick Farrell, CEO of ResMed, a longtime Medtrade exhibitor. “This quarter our team delivered strong double-digit growth in the Americas region, with solid global constant currency growth of 9%. Customers have responded to the value proposition of our Air Solutions platform, including the efficiencies it brings to their businesses and its ability to help them drive even better patient outcomes through connected care.
“We continue to build on our offerings across our strategy for both products and informatics solutions,” continued Farrell via press release. “This quarter we announced the close of the Inova transaction, which allows us to expand our respiratory care offerings to include portable oxygen concentrators. With the acquisition of Brightree in April, we have established ourselves as the outright leader for cloud-based end-to-end solutions in HME, home health, and hospice channels.”